Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticoagulation Using Rivaroxaban on Top of Aspirin in Recent Stroke/Transient Ischemic Attack Patients With Intracranial Atherosclerotic Stenosis (AA-ICAS)

NCT05700266 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.

NCT NCT05700266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05700266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticoagulation Using Rivaroxaban on Top of Aspirin in Recent Stroke/Transient Ischemic Attack Patients With Intracranial Atherosclerotic Stenosis (AA-ICAS)
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 30, 2023
Completion date
December 31, 2024
Enrollment
1,180 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial atherosclerosis, ischemic stroke, stenosis